2Yoshiuchi K, Matsuhisa M, Katakami N, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes[J]. Endocr J,2008,55 (3) :503-507.
3Kosecki SM, Rodgers PT, Adams MB. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy[J]. Ann Pharmaeother, 2005, 39 ( 9 ) : 1557- 1560.
5Rahlenbeek SI. Monitoring diabetic control in developing countries: a review of glyeated haemoglobin and fruetosamine assaysEJ3. Trop Doet, 1998,28 ( 1 ) : 9-15.
6Kennedy DM,Johnson AB, Hill PG. A comparison of automated fruetosamine and HbAlc methods for monitoring diabetes in pregnaneyEJ3. Ann Clin Biochem, 1998,35 (Pt2) : 283-289.
3Takahashi S,Uchino H,Shimizu T,et al.Comparison of glycated albumin and glycated hemoglobin in type 2 diabetic pentients:usefulness of GA for evaluation of sort-term changes in glycemic control.Endoce J,2007,54:139-144.
4Paroni R,Ceriotti F,Galanello R,et al.Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.Clin Biochem,2007,40:1398-1405.
5Peacock TP,Shihabi ZK,Bleyer AJ,et al.Comparison of glycated albumin and hemoglobin Alc levels in diabetic subjects on hemodialysis.Kidney Int,2008,73:1062-1068.
6Inaba M,Okuno S,Kumeda Y,et al.Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes:effect of anemia and erythropoietin injection.J Am Soc Nephrol,2007,18:896-903.
7Masafumi Koga, Soj! Kasayama. Clinical impact of glycated albu- min as another glycemic control marker[J]. Endocrine Journal, 2010,57(9) :751.
8Satomi Takahashi, Hiroshi Uchino, Tomoaki Shimizu, et al. Com parison of glycated albumin (GA) and Glycated hemoglobin (HbAlc) in Type 2 diabetic patients: usefulness of GA for Evalu- ation of short - term changes in glycemic eontrol[J]. Endocrine Journal,2007,54(1) : 139.
9Reiko Kisugi, Takuji Kouzuma, Tamotsu Yamamoto, et al. Struc- tural and glycation site changes of albumin in diabetic patient with very high glycated albumin[J]. Clinica Chimica Acta. 2007,382: 59.
10The International Expert Committee. In-ternational Expert Com- rnittee report on he role of the A1C assay in the diagnosis f diabe- tes[J]. Diabetes Care, 2009 ,32 :1327.
5American Diabetes Association. Executive Summary:Standards of Medical Care in Diabetes 2010[-J. Diabetes Care,2010,33(Suppl 1) :s4.
6Basta G, Schmidt AM, de Caterina R. Advanced glycation end products and vascular inflammation:implications for accerlerated atherosclerosis in diabetes. Cardiovase Res ,2004,63:582-592.
7Djufic D, Jakovbevic V, Rasise MA, et al. Homocys--teine folic acid and coronary artery disease:possibleimpact on prognosis and therapy. Indian J chest Dis Allied SCI,2008,50:39-48.
8Jarosz A, Nowicka G. C-reactive protein and homocysteine as risk factors of atherosclerosis. Przegl Lek ,2008,65:268-272.
9American Diabetes Association.Standards of medical care in diabetes-2011[J].Diabetes Care,2011,35(1):11-61.
10Hollander MH,Paarlberg KM,Huisjes AJ.Gestationaldiabetes:a review of the current literature and guide-lines[J].Obstet Gynecol Surv,2007,62(2):125-136.
